|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| C07D 405/14 | |||
| C07D 413/14 | |||
| C07D 401/04 | |||
| C07D 413/04 | |||
| C07D 417/04 | |||
| C07D 241/42 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61K 31/4375 | |||
| A61P 37/00 |
| (11) | Patento numeris | 3390389 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16840344.2 |
| Europos patento paraiškos padavimo data | 2016-12-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/067112 |
| Data | 2016-12-16 |
| (87) | Numeris | WO 2017/106607 |
| Data | 2017-06-22 |
| (30) | Numeris | Data | Šalis |
| 201562268765 P | 2015-12-17 | US | |
| 201662353603 P | 2016-06-23 | US |
| (72) |
SHERER, Brian A., US
BRUGGER, Nadia, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS |
| POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS |